Richard W. Paul & Associates’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-132
| Closed | -$1.42K | – | 345 |
|
|
2024
Q4 | $1.42K | Hold |
132
| – | – | ﹤0.01% | 441 |
|
|
2024
Q3 | $750 | Hold |
132
| – | – | ﹤0.01% | 476 |
|
|
2024
Q2 | $557 | Hold |
132
| – | – | ﹤0.01% | 473 |
|
|
2024
Q1 | $672 | Hold |
132
| – | – | ﹤0.01% | 479 |
|
|
2023
Q4 | $1.23K | Hold |
132
| – | – | ﹤0.01% | 443 |
|
|
2023
Q3 | $865 | Sell |
132
-43
| -25% | -$282 | ﹤0.01% | 453 |
|
|
2023
Q2 | $1.42K | Sell |
175
-120
| -41% | -$976 | ﹤0.01% | 452 |
|
|
2023
Q1 | $2.53K | Hold |
295
| – | – | ﹤0.01% | 424 |
|
|
2022
Q4 | $2.73K | Buy |
+295
| New | +$2.73K | ﹤0.01% | 409 |
|